FORD KATHLEEN — SEC insider filings

SEC reporting owner CIK 1785406. 21 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2020-09-15 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kura Oncology, Inc. (KURA)Chief Operating Officer21—19 legs · 80,741 sh · $1,629,64921

Insider filings — FORD KATHLEEN

FiledFormIssuerReported transactionsSource
2026-11-184Kura Oncology, Inc. (KURA)Sale (S): 7,042 @ $7.44 · Sale (S): 3,668 @ $7.46EDGAR
2026-09-294Kura Oncology, Inc. (KURA)Sale (S): 6,906 @ $10.50 · Sale (S): 3,668 @ $10.75EDGAR
2026-05-204Kura Oncology, Inc. (KURA)Sale (S): 2,257 @ $9.08EDGAR
2026-01-274Kura Oncology, Inc. (KURA)Sale (S): 1,813 @ $8.46EDGAR
2026-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-11-144Kura Oncology, Inc. (KURA)Grant/award (A): 48,900 @ $0 · Sale (S): 6,902 @ $11.18EDGAR
2025-09-294Kura Oncology, Inc. (KURA)Grant/award (A): 48,900 @ $0 · Sale (S): 6,892 @ $8.94EDGAR
2025-05-194Kura Oncology, Inc. (KURA)Sale (S): 1,558 @ $6.28EDGAR
2025-01-284Kura Oncology, Inc. (KURA)Sale (S): 1,817 @ $7.87EDGAR
2025-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 185,000 (derivative) @ $0EDGAR
2024-11-194Kura Oncology, Inc. (KURA)Sale (S): 526 @ $16.03EDGAR
2024-01-314Kura Oncology, Inc. (KURA)Sale (S): 1,496 @ $17.80EDGAR
2024-01-044Kura Oncology, Inc. (KURA)Grant/award (A): 185,000 (derivative) @ $0EDGAR
2023-02-214Kura Oncology, Inc. (KURA)Grant/award (A): 185,000 (derivative) @ $0EDGAR
2023-01-314Kura Oncology, Inc. (KURA)Sale (S): 1,821 @ $13.89EDGAR
2022-01-284Kura Oncology, Inc. (KURA)Grant/award (A): 21,900 @ $0 · Grant/award (A): 171,000 (derivative) @ $0EDGAR
2021-03-174Kura Oncology, Inc. (KURA)Option exercise (M): 6,250 @ $19.43 · Sale (S): 6,250 @ $29.43 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2021-01-284Kura Oncology, Inc. (KURA)Grant/award (A): 140,000 (derivative) @ $0EDGAR
2020-12-164Kura Oncology, Inc. (KURA)Option exercise (M): 6,250 @ $19.43 · Sale (S): 6,250 @ $40.60 · Option exercise (M): 3,125 @ $19.43 · Sale (S): 3,125 @ $40.60 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2020-11-124Kura Oncology, Inc. (KURA)Option exercise (M): 6,250 @ $19.43 · Sale (S): 6,250 @ $39.43 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2020-09-154Kura Oncology, Inc. (KURA)Option exercise (M): 6,250 @ $19.43 · Sale (S): 6,250 @ $29.43 · Option exercise (M): 6,250 @ $19.43 · Sale (S): 6,250 @ $29.43 · Option exercise (M): 6,250 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1785406 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs